Medicare AdvantageBilling CodesMedium impact
MA05.027d, Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) for Treating Life-threatening Ventricular Tachyarrhythmia
Independence Blue Cross·Cardiology, Cardiothoracic Surgery·Coding
Effective date
Apr 2, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA05.027d regarding Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) for treating life-threatening ventricular tachyarrhythmia has been reissued with an effective date of April 2, 2025. This is a coding-related policy update that may affect billing procedures for S-ICD devices and related services.
Action Required
By April 2, 2025: Billing team should review the complete policy document at the source URL to understand specific coding requirements for S-ICD procedures under Medicare Advantage plans. Update billing procedures and encounter forms as needed based on the full policy details.